Skip to main content
editorial
. 2021 Feb 17;22(4):1990. doi: 10.3390/ijms22041990
ATC Anaplastic thyroid cancer
anti-CTLA-4 anti-cytotoxic T lymphocyte antigen 4
anti-PD-1 anti-programmed cell death protein-1
anti-PD-L1 anti-programmed cell death ligand-1
BRAF B-Raf (rapidly accelerated fibrosarcoma) proto-oncogene/threonine protein kinase B-
CAMP 3′,5′-cyclic adenosine monophosphate
CH congenital hypothyroidism
DIABLO Diablo homolog
DTC Differentiated thyroid cancer
EBV Epstein–Barr Virus
FGF2 Fibroblast Growth Factor 2
FOXE1 transcription factor Forkhead box E
FTC Follicular thyroid cancer
GD Graves’ Disease
HUVECs Human umbilical vein endothelial cells
IC immune checkpoints
MKI(s) Multi-kinase inhibitor(s)
MTC Medullary thyroid cancer
PROX1 Prospero homeobox 1
PTC Papillary thyroid cancer
RAI Radioiodine
SMAC second mitochondria-derived activator of caspases
TC Thyroid cancer
TKIs Tyrosine-kinase inhibitor(s)
TSH Thyroid-stimulating hormone
TSHB Thyroid-stimulating hormone beta
TSHR Thyroid-stimulating hormone receptor
TUSC2 Tumour Suppressor Candidate 2